Sugar modified nucleosides
First Claim
1. A nucleoside having the structure:
-
wherein;
R2 is selected from the group consisting of H, OH, alkoxy, aralkoxy and aryloxy;
R3 and R5 are independently selected from the group consisting of OH, OCEPA and a hydroxyl blocking group;
X is selected from the group consisting of O and CH2;
B is a nucleoside base;
when X is CH2, R1′
, R3′
, R4′ and
R5′
are independently selected from the group consisting of H, CN, N3, NO2, CF3, alky, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, provided that R1′
, R3′
, R4′ and
R5′
cannot all be H at the same time and R4′
is not a label;
when X is O, R4′ and
R5′
are H, and R1′
is selected from the group consisting of N3, NO2, CF3, alky, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, where the substituted portion of at least one of the substituted alkyl substituted aralkyl and substituted aryl is selected from the group consisting of NO2, N3, CF3, SH, SR, COOH, COOR, SO3H SO3R, F, Cl, Br, I, Ts, Ac, CF3CO, acyl, where R is selected from lower alkyl aralkyl and aryl; and
R3′
is selected from the group consisting of CN, N3, NO2, CF3, alkyl, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, where the substituted portion of at least one of the substituted akl, substituted aralkyl and substituted aryl is selected from the group consisting of CN, NO2, N3, CF3, NH2, NR2, OR, SH, SR, COOH, COOR, SO3R, F, Cl, Br, I Ts, Ac, CF3CO, acyl, where R is selected from lower alkyl, aralkyl and aryl; and
wherein any alkyl portion of R1′
, R3′
, R4′ and
R5′
is C1 to C10, linear, branched, saturated or unsaturated.
1 Assignment
0 Petitions
Accused Products
Abstract
A number of modified nucleosides are disclosed composed of modified sugar moieties which contain substituents at C1 and C4 positions, or branched substituents at C3 and C5 positions of deoxyribose or ribose. Each nucleoside is converted to or properly protected and then converted to the corresponding phosphoramidites. These phosphoramidites are used to assemble oligonucleotides in which there is at least one of the forenoted nucleosides. These sugar modified oligonucleotides have the potential to be used as antisense therapies since they are expected to enhance nuclease resistance and cellular uptake while they maintain sequence-specificity and affinity to nucleic acid targets in vitro or in vivo.
-
Citations
3 Claims
-
1. A nucleoside having the structure:
-
wherein; R2 is selected from the group consisting of H, OH, alkoxy, aralkoxy and aryloxy;
R3 and R5 are independently selected from the group consisting of OH, OCEPA and a hydroxyl blocking group;
X is selected from the group consisting of O and CH2;
B is a nucleoside base;
when X is CH2, R1′
, R3′
, R4′ and
R5′
are independently selected from the group consisting of H, CN,N3, NO2, CF3, alky, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, provided that R1′
, R3′
, R4′ and
R5′
cannot all be H at the same time and R4′
is not a label;
when X is O, R4′ and
R5′
are H, andR1′
is selected from the group consisting of N3, NO2, CF3, alky, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, where the substituted portion of at least one of the substituted alkyl substituted aralkyl and substituted aryl is selected from the group consisting of NO2, N3, CF3, SH, SR, COOH, COOR, SO3H SO3R, F, Cl, Br, I, Ts, Ac, CF3CO, acyl, where R is selected from lower alkyl aralkyl and aryl; and
R3′
is selected from the group consisting of CN, N3, NO2, CF3, alkyl, substituted alkyl, aralkyl, substituted aralkyl, aryl, and substituted aryl, where the substituted portion of at least one of the substituted akl, substituted aralkyl and substituted aryl is selected from the group consisting of CN, NO2, N3, CF3, NH2, NR2, OR, SH, SR, COOH, COOR, SO3R, F, Cl, Br, I Ts, Ac, CF3CO, acyl, where R is selected from lower alkyl, aralkyl and aryl; and
wherein any alkyl portion of R1′
, R3′
, R4′ and
R5′
is C1 to C10, linear, branched, saturated or unsaturated.- View Dependent Claims (2, 3)
-
Specification